别名: | CMP; 3'-5'-cyclic adenosine monophosphate; SCHEMBL1264; ZINC12502232; Cyclic adenylic acid; BRN 0052645; Adenosine cyclic monophosphate; 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, adenosine deriv.; C00575; (4aR,6R,7R,7aS)-6-(6-Aminopurin-9-yl)-2-oxo-tetrahydro-2-lambda*5*-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol; cyclic 3',5'-Adenylic acid; Adenosine-3',5'-cyclicmonophosphate; Adenosine 3′,5′-cyclic monophosphate; Cyclic AMP; EINECS 200-492-9; NSC 94017; Adenosine 3',5'-cyclic phosphate; Adenosine 3',5'-cyclophosphoric acid; Adenosine cyclic 3',5'-monophosphate; CHEBI:17489; 3′,5′-Cyclic AMP; ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE; Adenosine 3′,5′-cyclophosphate; Adenosine 3',5'-cyclophosphate; ST5298854; 11002-78-1; Adenosine 3',5'-cyclic monophosphate; Adenosine cyclic 3',5'-(hydrogen phosphate); 54532-48-8; 4-26-00-03618 (Beilstein Handbook Reference); adenosine 3',5'-(hydrogen phosphate); cyclic Adenosine 3',5'-phosphate; cyclic Adenosine 3',5'-monophosphate; (S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidine-3-yl)-1,4-anhydro-D-ribitol cyclic 3',5'-(hydrogen phosphate); AIDS008698; CCRIS 4291; 4H-furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)-; Adenosine 3',5'-monophosphate; Formycin cyclic 3',5'-monophosphate; (1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol; Adenosine 3',5'-phosphate; Adenosine, cyclic 3',5'-(hydrogen phosphate); A9501_SIGMA; (1S,6R,8R,9R)-8-(6-amino-9-purinyl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol; CYCLIC-3',5'-(HYDROGEN PHOSPHATE)ADENOSINE; Lopac0_000084; D-Ribitol, 1-C-(7-amino-1H-pyrazolo(4,3-d)pyrimidine-3-yl)-1,4-anhydro-, cyclic 3',5'-(hydrogen phosphate), (S)-; 3',5'-AMP; (1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-keto-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol; Adenosine 3',5'-phosphate monohydrate; Adenosine cyclic 3',5'-phosphate; AIDS-008698; EU-0100084 |